Anna Song, Ph.D., is a regulatory professional and materials scientist who currently serves as an Associate Regulatory Affairs Director at AstraZeneca. With a passion for health and problem-solving, Anna has substantial experience in drug delivery formulations and advanced microscopy techniques. Previously, Anna held roles in various organizations, including Emergent BioSolutions, where they managed global regulatory affairs, and Booz Allen Hamilton as a Senior Regulatory Science Consultant for the FDA. Anna's educational journey encompasses research in drug formulation at Michigan State University, where they contributed to significant advancements in polymer composites and drug delivery systems. Anna aims to enhance healthcare accessibility through involvement in non-profit health initiatives.
This person is not in the org chart
This person is not in any teams
This person is not in any offices